A Study of KC1036 in Adolescents With Advanced Ewing Sarcoma
Clinical trial NCT06564272 · RECRUITING
Trial details
- NCT number
- NCT06564272
- Sponsor
- Beijing Konruns Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-27
- Primary completion
- 2027-04-01
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.